文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

卵巢癌炎症指标的知识图谱与文献计量分析

Knowledge graph and bibliometric analysis of inflammatory indicators in ovarian cancer.

作者信息

Zhang Liyan, Guo Linlin, Wang Haiyan, Yang Huan, Dong Jiarui

机构信息

Department of Functional Examination, Obstetrics and Gynecology Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.

出版信息

Front Oncol. 2025 Jun 30;15:1533537. doi: 10.3389/fonc.2025.1533537. eCollection 2025.


DOI:10.3389/fonc.2025.1533537
PMID:40661780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12257306/
Abstract

BACKGROUND: Chronic inflammation is a type of inflammatory response that lasts for a relatively long period of time. Occurrence and development of many diseases are closely related to chronic inflammation. In the process of the occurrence of certain tumors, chronic inflammation also plays an important role. For example, chronic inflammation of the stomach caused by chronic Helicobacter pylori infection is an important risk factor for gastric cancer. Inflammatory cells can release reactive oxygen species (ROS), cytokines and so on which can induce DNA damage in cells, activate oncogenes and suppress tumor suppressor genes, thus promoting the proliferation, survival, migration and invasion of tumor cells. Recent studies have shown that great progress has been made in understanding the role of chronic inflammation in ovarian cancer. However, there has been no bibliometric analysis in this research field yet. The aim of this study is to review the knowledge structure and research hotspots of inflammatory indicators in ovarian cancer through bibliometric methods. METHODS: A computer search was conducted on 595 articles related to inflammatory markers and ovarian cancer in the Web of Science Core Collection (WoSCC) database from 2000 to 2024. Relevant software such as VOSviewer, CiteSpace, R package "bibliometrix" and Microsoft Office Excel 2019 were used to conduct a comprehensive bibliometric analysis on these related articles and analyze the research status and development directions over the past more than 20 years. RESULTS: A total of 595 articles related to inflammatory markers and ovarian cancer were included in this study. Among them, the United States and China had the largest number of published articles. Global publications have been steadily increasing every year with reaching a peak in 2023. The United States had the largest number of publications and followed by China and Italy. Among them, Harvard University in the United States had the largest number of published papers, approximately 100 and followed by the National Institutes of Health (NIH) and the NIH National Cancer Institute (NCI) with 52 each. CHATURVEDI AK ranked first in the total citation number of published articles, with a total of 683 citations and HILDESHEIM A ranked second in the total citation number, with a total of 651 citations. The number citations are highlighting their significant contributions to this field. The two magazines of the CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION and JOURNAL OF OVARIAN RESEARCH had the most published articles and followed by Cancer and PLOS ONE. The article "COUSSENSLU, 2002, NATURE V420, P860, 00110, 1030/NATURE01322" was the most frequently cited one, with 46 citations. The article "CRVENNKOY SL2010, CELL7140 2883, 00110 016402LL 201001025" was cited 38 times and ranked second. The analysis results of CiteSpace show that ovarian cancer, inflammation and prognosis are identified as the keywords with the highest frequencies, indicating the core research focuses and directions in this area. The results of the research topics in this area show that from 2019 to 2024, the main themes were ovarian cancer, inflammation and so on. Through the analysis of the research trends, it can be known that from 2019 to 2024, ovarian cancer and inflammation were the main trends, which is the analysis of trend topics. All in all, the indicators of ovarian cancer and inflammation represent the frontier research directions in this field. CONCLUSION: This is the first bibliometric study that comprehensively summarizes the research trends and progress of inflammatory indicators in ovarian cancer. The information in this study has summarized the recent research frontiers and hotspots. The results will provide references for scholars to study the early diagnosis and treatment of inflammatory indicators and ovarian cancer.

摘要

背景:慢性炎症是一种持续时间相对较长的炎症反应。许多疾病的发生和发展都与慢性炎症密切相关。在某些肿瘤的发生过程中,慢性炎症也起着重要作用。例如,幽门螺杆菌慢性感染引起的胃部慢性炎症是胃癌的重要危险因素。炎症细胞可释放活性氧(ROS)、细胞因子等,可诱导细胞DNA损伤,激活癌基因并抑制肿瘤抑制基因,从而促进肿瘤细胞的增殖、存活、迁移和侵袭。最近的研究表明,在理解慢性炎症在卵巢癌中的作用方面取得了很大进展。然而,该研究领域尚未进行文献计量分析。本研究的目的是通过文献计量方法综述卵巢癌炎症指标的知识结构和研究热点。 方法:在科学网核心合集(WoSCC)数据库中对2000年至2024年与炎症标志物和卵巢癌相关的595篇文章进行计算机检索。使用VOSviewer、CiteSpace、R包“bibliometrix”和Microsoft Office Excel 2019等相关软件对这些相关文章进行全面的文献计量分析,并分析过去20多年的研究现状和发展方向。 结果:本研究共纳入595篇与炎症标志物和卵巢癌相关的文章。其中,美国和中国发表的文章数量最多。全球发表量逐年稳步增加,在2023年达到峰值。美国发表量最多,其次是中国和意大利。其中,美国哈佛大学发表的论文数量最多,约100篇,其次是美国国立卫生研究院(NIH)和美国国立癌症研究所(NCI),各有52篇。查图尔维迪·阿克在发表文章的总被引次数中排名第一,共有683次引用,希尔德斯海姆·A在总被引次数中排名第二,共有651次引用。这些被引次数凸显了他们对该领域的重大贡献。《癌症流行病学、生物标志物与预防》和《卵巢研究杂志》这两本杂志发表的文章最多,其次是《癌症》和《公共科学图书馆·综合》。文章“COUSSENSLU, 2002, NATURE V420, P860, O0110, 1030/NATURE01322”被引用次数最多,为46次。文章“CRVENNKOY SL20l0, CELL7140 2883, 00110 016402LL 201001025”被引用38次,排名第二。CiteSpace的分析结果表明,卵巢癌、炎症和预后被确定为出现频率最高的关键词,表明该领域的核心研究重点和方向。该领域的研究主题结果表明,2019年至2024年,主要主题是卵巢癌、炎症等。通过对研究趋势的分析可知,2019年至2024年,卵巢癌和炎症是主要趋势,这是趋势主题分析。总而言之,卵巢癌和炎症指标代表了该领域的前沿研究方向。 结论:这是第一项全面总结卵巢癌炎症指标研究趋势和进展的文献计量学研究。本研究中的信息总结了近期的研究前沿和热点。研究结果将为学者们研究炎症指标与卵巢癌的早期诊断和治疗提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0a/12257306/5fa0dd710526/fonc-15-1533537-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0a/12257306/5fa0dd710526/fonc-15-1533537-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0a/12257306/5fa0dd710526/fonc-15-1533537-g002.jpg

相似文献

[1]
Knowledge graph and bibliometric analysis of inflammatory indicators in ovarian cancer.

Front Oncol. 2025-6-30

[2]
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.

Updates Surg. 2025-6-28

[3]
The Black Book of Psychotropic Dosing and Monitoring.

Psychopharmacol Bull. 2024-7-8

[4]
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].

Epidemiol Prev. 2013

[5]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Health Technol Assess. 2001

[6]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[7]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[8]
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.

Health Technol Assess. 2024-10

[9]
Home treatment for mental health problems: a systematic review.

Health Technol Assess. 2001

[10]
Comprehensive Global Analysis of Future Trends in Artificial Intelligence-Assisted Veterinary Medicine.

Vet Med Sci. 2025-5

本文引用的文献

[1]
Role of C-reactive protein in disease progression, diagnosis and management.

Discoveries (Craiova). 2023-12-31

[2]
The prognostic and clinical value of neutrophil-to-lymphocyte ratio (NLR) in ovarian cancer: A systematic review and meta-analysis.

J Med Biochem. 2024-6-15

[3]
The Association of Kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.

Cancer Epidemiol Biomarkers Prev. 2023-10-2

[4]
Correlation of systemic immune-inflammatory response index with clinical data in patients with malignant ovarian tumor.

Am J Transl Res. 2023-5-15

[5]
Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review.

Int J Immunopathol Pharmacol. 2023

[6]
Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals.

J Ethnopharmacol. 2023-5-10

[7]
Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment.

Metabolites. 2023-1-13

[8]
The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer.

Health Sci Rep. 2022-11-22

[9]
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer.

Int J Clin Oncol. 2023-2

[10]
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity.

Clin Cancer Res. 2023-3-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索